Clinical Trial Update: Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update analyzing empagliflozin’s effect on tissue sodium content in chronic heart failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Chronic Heart Failure | Phase 2 | Status: COMPLETED